The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Related News Articles

Headline
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…
Headline
The Advanced Research Projects Agency for Health Jan. 13 announced a program to develop and implement artificial intelligence tools for…
Headline
The latest estimates on overdose deaths released yesterday by the Centers for Disease Control and Prevention show that as of August 2025, deaths fell…
Headline
A Centers for Disease Control and Prevention report found a drastic increase in alcohol-related emergency department visits from 2003-2004 to 2021-2022. The…
Headline
The AHA, in partnership with Press Ganey, Jan. 15 released the fourth in a series of workbooks leaders can use to understand and overcome challenges in…
Headline
UnitedHealth Group announced Jan. 14 that it launched a six-month pilot program to reduce Medicare Advantage payment processing times by half for rural…